Synthesis of Thorium Dioxide Doped with Gadolinium Via a Wet Chemical Route

Total Page:16

File Type:pdf, Size:1020Kb

Synthesis of Thorium Dioxide Doped with Gadolinium Via a Wet Chemical Route FACULTY OF SCIENCE Synthesis of thorium dioxide doped with gadolinium via a wet chemical route Peter Zsabka Promotor: Prof. Dr. Koen Binnemans Molecular Design and Synthesis,Department of Thesis presented in Chemistry, KU Leuven fulfilment of the requirements Co-promotor: for the degree of Master of Science Prof. Dr. Thomas Cardinaels in Chemistry Radiochemical Analysis and Processes, Institute for Nuclear Materials Science, SCK•CEN Academic year 2014-2015 © Copyright by KU Leuven Without writtenpermission of the promotors and the authors it is forbidden to reproduce or adapt in any form or by any means any part of this thesis. Requests for obtaining the right to reproduce or utilize parts of this publication should be addressed to KU Leuven, Faculteit Wetenschappen, Geel Huis, Kasteelpark Arenberg 11 bus 2100, 3001 Leuven (Heverlee), Tel.: +32 16 32 14 01. A written permission of the promotors is also required to use the methods, products, schematics and programs described in this work for industrial or commercial use, and for submitting this publication in scientific contests. I Abstract (English) Thorium gained interest as a source of 233U, an alternative to 235U-based nuclear fuel, since the onset of the commercial utilization of nuclear power. Nowadays enormous reserves of thorium(IV) nitrate and thoria (ThO2) have been built up as a side product of extraction of rare-earth elements from monazite ore. Without valorisation such reserves only count as highly radioactive waste that needs to be securely buried and monitored. From a technological point of view, the most straightforward utilization of thorium is its use as ThO2 ceramic pellets in pressurized water reactors. Fabrication of high density ThO2 pellets is more difficult compared to currently used UO2 pellets due to the very high melting point of thoria. Until know, pilot projects in which thoria pellets were used usually applied extensive mechanical treatment (milling or grinding) to improve the sinterability of pellet feed material. Wet chemical synthetic routes are generally considered as more safe compared to dry mechanical treatment, as hazardous dust formation can be avoided and powder properties can be engineered to some extent. Among others, the optimal process parameters of the oxalate precipitation route has been intensively investigated in the past as it is a cheap and simple wet chemical method and a candidate for industrial upscaling. Wet chemical synthesis routes were applied to investigate the feasibility of fabricating high- density thoria pellets without having recourse to any mechanical treatment of precursor powder feed material. Three synthetic routes were studied. On the basis of solid literature data, nano-sized thorium(IV) oxalate hexahydrate and derived thoria powder was obtained reproducibly under carefully selected reaction and heat-treatment parameters. As the powders proved to be highly prone to form agglomerates, the sintered pellets shown sign of heterogeneous sintering, and as a consequence reproducibility in terms of both pellet density and pellet integrity was very low. By adding trace amount of alumina sintering aid to the thoria powder, significant improvement in density has been attained. Further studies are needed to draw a definite conclusion whether the addition of sintering aid (either alumina or niobia) could ameliorate the abovementioned shortcomings of oxalate-route derived powder. The second method was homogenous precipitation route, in which diethyl oxalate was thermally decomposed to generate in situ oxalic acid. The latter type of thoria powder was fluffy and free flowing.Pellets produced via homogeneous precipitation route sintered to low densities, being unfavourable with respect to neutron economy during breeding, but more favourable for reprocessing due to ease in dissolution of irradiated pellets. In the third route tetrabutylammonium oxalate was used as precipitating reagent. In the latter case the precipitate could not be thermally decomposed and further processing of the material was abandoned. The second goal of the thesis was to study the effect of gadolinium doping on lattice parameter of thoria powder and sintered pellet samples.The Gd-dopant serves as a consumable neutron absorber, the use of which is promoted by the aim of obtaining higher neutron economy during the irradiation cycle.For the purpose of studying the effect of doping, the well-established oxalate precipitation route was applied. Lattice parameters of sintered Gd-doped thoria pellets fabricated from wet chemical route- derived powder are reported here for the first time. Evidence is given on the solid solution II formation during the sintering process. Lattice parameter values of powder samples were determined after calcination at 700 °C and 1000 °C for 1 h. The X-ray diffractogram of these samples showed the presence of two cubic phases. Lattice parameter values were subsequently determined on pellets that were sintered at 1750 °C for 8 h. Sintering resulted in one single cubic phase for all applied dopant concentration indicating solid solution formation. Besides the decrease of lattice parameter, gadolinium doping on thoria also caused a progressive decrease in the sintered pellet densities with higher dopant concentration. Although wet chemical routes are considered to provide highly homogeneous distribution of constituting elements, evidence was found, that due to crystallization processes and thermal decomposition patterns during calcination of precursor powders leave back inclusions with composition different from that of the bulk matrix. The amount of inhomogeneity is nonetheless lower than the limit of detection attainable with XRD method, and was only possible to capture by EDS. III Abstract (Nederlands) Thorium wekte belangstelling als een bron van 233U, een alternatief van 235U-gebaseerde nucleaire brandstof, sinds het begin van commercieel gebruik van kernenergie. In deze tijd zijn enorme reserves thorium(IV) nitraat en thorium dixoxide (ThO2) ontstaan als een bijproduct van extractie van zeldzame aardelementen uit monaziet erts. Zonder valorisatie worden zodanige reserves alleen als hoogradioactief afval geacht dat veilig moet begraven en gecontroleerd worden. Ten opzichte van technologie is de eenvoudigste benuttiging van thorium als ThO2 keramische pellets in drukwaterreactors worden gebruikt. Fabricage van ThO2 pellets met hoge dichtheid is meer ingewikkeld in vergelijking met de tegenwoordig gebruikte UO2 pellets vanwege het heel hoge smeltpunt van thorium dioxide. Tot nu toe hebben piloot projecten waarbij thorium dioxide pellets werden gebruikt gewoonlijk extensieve mechanische behandeling (malen of vermalen) toegepast om de sinterabiliteit van pellet voedingsmateriaal te verbeteren. Natte chemische synthetische route is in het algemeen meer veilig geacht dan droge mechanische behandeling, want gevaarlijke stofvorming kan vermeden worden en poedereigenschappen kunnen tot op zekere hoogte gepland worden. Onder anderen werden de optimale procesparameters van oxalaat precipitatie weg in het verleden intensief onderzocht, omdat deze een goedkope en eenvoudige natte scheikundige methode is en een kandidaat voor industriele uitbreiding is. Natte chemische synthetische route werden aangewend om de uitvoerbaarheid van productie van thorium dixoxide pellets met hoge dichtheid te onderzoeken zonder toepassing van enige mechanische behandeling van precursor poeder voedingsmateriaal. Drie synthetische routes werden bestudeerd. Op grond van vaste literatuurgegevens werden thorium(IV) oxalaat hexahydraat en afkomstig thorium dixoxide poeder in nano-maat reproduceerbaar met zorgvuldig geselecteerde reactie en warmtebehandeling parameters verkregen. Aangezien dat gebleken is dat de poeders zeer vatbaar voor de vorming van agglomeraten zijn, tonen de gesinteerde pellets het teken van heterogene sinteren, en als gevolg de reproducibiliteit ten aanzien van zowel pellet dichtheid als pellet integriteit zeer laag was. Door toevoeging van spoor hoeveelheid aluminiumoxide sinterhulpmiddel aan thorium dixoxide poeder, werd aanzienlijke verbetering betreffende dichtheid bereikt. Verdere studies zijn nodig voor het trekken van definitieve conclusie of de toevoeging van sinterhulpmiddel (hetzij aluminiumoxide hetzij niobium oxide) de bovenvermelde tekortkomingen van uit oxalaat-route komende poeder zou kunnen verbeteren. De tweede methode was de homogene precipitatie route, waarbij diethyl oxalaat thermisch ontbonden was om in situ oxaalzuur voort te brengen. Het laatstgenoemde type van thorium dioxide poeder was donzig en vrij vloeibaar. Pellets geproduceerd via homogene precipitatie route werd tot lage dichtheid gesinteerd, welk ongunstig aangaande neutron economie gedurende voortbrenging is, maar gunstiger is voor reprocessing ten gevolge van vergemakkelijking in het oplossen van bestraalde pellets. Bij de derde route werd tetrabutylammonium oxalaat als precipitatie reagens gebruikt. In voormeld geval kon het precipitaat thermisch niet ontbonden worden en verdere verwerking van het materiaal was gestopt. De tweede doelstelling van het thesis (proefschrift) was om de invloed van de doping van gadolinium op rooster parameter van thorium dioxide poeder en gesinteerde pellet monsters IV te bestuderen. Gd-dopant (Gd-doping agens) dient als een verbruikbare neutron absorber. Het gebruik ervan wordt met de bedoeling bijgestaan om hogere neutron economie tijdens de bestralingscyclus te krijgen. Om de invloed van doping te bestuderen, werd de goed
Recommended publications
  • Gadolinium Information
    Gadolinium Information Gadolinium contrast agents are frequently utilized during MRI examinations in order to improve the exam and interpretation. They are not always needed. Your radiologist will determine whether or not gadolinium contrast is needed for your MRI examination. Gadolinium contrast agents are quickly eliminated from the body in healthy individuals. With normal functioning kidneys, the retention of gadolinium in soft tissues of the body is very small and may not even be detectable. However, some patients who receive multiple doses of contrast, including pregnant women and children, might be at increased risk of gadolinium remaining in the body for longer periods of time. To date, there are no known harmful effects of gadolinium remaining in the body for long periods of time in patients who have normal kidneys. In patients who have poorly functioning kidneys, a condition called nephrogenic systemic sclerosis (NSF) can occur. This causes debilitating thickening of the skin and other tissues. This only occurs in patients with poorly functioning kidneys. Your kidney function will be checked prior to receiving gadolinium contrast agent if needed. Other side-effects can occur even in patients with healthy kidneys. Some patients report pain, tiredness, and muscle aches after receiving gadolinium contrast but these conditions have not been directly linked to the administration of the gadolinium. Allergic reactions can also occur, as with any drug. If you have questions regarding your MRI examination today, please ask your MRI Technologist. MEDICATION GUIDE MULTIHANCE® (məl-tē-han(t)s) (gadobenate dimeglumine) Injection for intravenous use What is MULTIHANCE? • MULTIHANCE is a prescription medicine called a gadolinium-based contrast agent (GBCA).
    [Show full text]
  • Gadolinium Speciation
    Gadolinium Speciation Peter Caravan Martinos Center for Biomedical Imaging Institute for Innovation in Imaging Massachusetts General Hospital and Harvard Medical School Conflicts of Interest Stock ownership (>5%): Reveal Pharmaceuticals; Collagen Medical; Factor 1A LLC. Research grants: Pfizer; Pliant Pharmaceuticals; Biogen; Agilent; Pharmakea; Siemens. Consulting: Guerbet; Bayer; Collagen Medical; UCB Biopharma; Pfizer. What do we mean by speciation? What is the chemical form of the gadolinium in tissue? Chelated Gd Dissociated Gd The GBCA remains intact Dissociation of the GBCA Gd3+ ion Is Gd bound to a low molecular weight ligand? Is Gd part of some inorganic material like hydroxyapatite? Is Gd bound to a macromolecule? If so, which one? Where is the Gd distributed within tissue? Extra vs intracellular? In which cellular compartments? Why do we care about speciation? • The chemical form of Gd may inform its potential toxicity • Mineralized, insoluble Gd may be less toxic than soluble protein bound Gd (hypothesis) • The chemical form may also inform whether the Gd will be ultimately eliminated. Intact chelate may be expected to eventually clear the body (hypothesis). • The chemical form and location may guide chelation therapy strategies. Hierarchy of relevance of the data Human in vivo Human ex vivo Animal in vivo Animal ex vivo Solutions To model ex vivo Water solutions Tweedle MF. Gadolinium deposition: Is it chelated or dissociated gadolinium? How can we tell? Magn Reson Imaging. 2016;34(10):1377–82. How do GBCAs differ • Thermodynamics:
    [Show full text]
  • ACR Manual on Contrast Media
    ACR Manual On Contrast Media 2021 ACR Committee on Drugs and Contrast Media Preface 2 ACR Manual on Contrast Media 2021 ACR Committee on Drugs and Contrast Media © Copyright 2021 American College of Radiology ISBN: 978-1-55903-012-0 TABLE OF CONTENTS Topic Page 1. Preface 1 2. Version History 2 3. Introduction 4 4. Patient Selection and Preparation Strategies Before Contrast 5 Medium Administration 5. Fasting Prior to Intravascular Contrast Media Administration 14 6. Safe Injection of Contrast Media 15 7. Extravasation of Contrast Media 18 8. Allergic-Like And Physiologic Reactions to Intravascular 22 Iodinated Contrast Media 9. Contrast Media Warming 29 10. Contrast-Associated Acute Kidney Injury and Contrast 33 Induced Acute Kidney Injury in Adults 11. Metformin 45 12. Contrast Media in Children 48 13. Gastrointestinal (GI) Contrast Media in Adults: Indications and 57 Guidelines 14. ACR–ASNR Position Statement On the Use of Gadolinium 78 Contrast Agents 15. Adverse Reactions To Gadolinium-Based Contrast Media 79 16. Nephrogenic Systemic Fibrosis (NSF) 83 17. Ultrasound Contrast Media 92 18. Treatment of Contrast Reactions 95 19. Administration of Contrast Media to Pregnant or Potentially 97 Pregnant Patients 20. Administration of Contrast Media to Women Who are Breast- 101 Feeding Table 1 – Categories Of Acute Reactions 103 Table 2 – Treatment Of Acute Reactions To Contrast Media In 105 Children Table 3 – Management Of Acute Reactions To Contrast Media In 114 Adults Table 4 – Equipment For Contrast Reaction Kits In Radiology 122 Appendix A – Contrast Media Specifications 124 PREFACE This edition of the ACR Manual on Contrast Media replaces all earlier editions.
    [Show full text]
  • Radiological Significance of Thorium Processing in Manufacturing
    Attention Microfiche User, . The original document from which this microfiche was made was found to contain some imperfection or imperfections that redtice full comprehension of some of the text despite the gcod technical quality of the microfiche itself. The imperfections may be: - missing or illegible pages/figures - wrong pagination - poor overall printing quality, etc. We normally refuse to microfiche such a document and request a replacement document (or pages) from the National INIS Centre concerned. However, our experience shows that many months pass before such documents are replaced. Sometimes the Centre is not able to supply a better copy or, in some cases, the pages that were supposed to be missing correspond to a wrong pagination only. Me feel that it is better to proceed with distributing the microfiche made of these documents than to withhold them till the imperfections are removed. If the removals are subsequestly made then replacement microfiche can be issued. In line with this approach then, our specific practice for microfiching documents with imperfections is as follows: 1. A microfiche of an imperfect document will be marked with a special symbol (black circle) on the left of the title. This symbol will appear on all masters and copies of the document (1st fiche and trailer fiches) even if the imperfection is on one fiche of the report only. 2. If imperfection is not too general the reason will be specified on a sheet such as this, in the space below. 3. The microfiche will be considered as temporary, but sold at the normal price. Replacements, if they can be issued, will be available for purchase at the regular price.
    [Show full text]
  • Cerium Oxide Nanoparticles and Gadolinium Integration
    Linköping Studies in Science and Technology Dissertation No. 1997 Peter Eriksson Peter FACULTY OF SCIENCE AND ENGINEERING Linköping Studies in Science and Technology, Dissertation No. 1997, 2019 Cerium Oxide Nanoparticles Department of Physics, Chemistry and Biology (IFM) Linköping University SE-581 83 Linköping, Sweden and Gadolinium Integration Cerium Oxide Integration Nanoparticles and Gadolinium Synthesis, Characterization and Biomedical Applications www.liu.se Peter Eriksson 2019 Linköping Studies in Science and Technology Dissertation No. 1997 Cerium Oxide Nanoparticles and Gadolinium Integration Synthesis, Characterization and Biomedical Applications Peter Eriksson Applied Physics Department of Physics, Chemistry & Biology Linköping University, Sweden Linköping 2019 Front cover: A cerium oxide nanoparticle with integrated gadolinium. Back cover: Cross-section of a gadolinium-cerium oxide nanoparticle and its displayed theragnostic properties: left) cerium undergo redox-reactions to scavenge reactive oxygen species and right) gadolinium shorten the T1-relaxation time of nuclei spins in water molecules. During the course of the research underlying this thesis, Peter Eriksson was enrolled in Forum Scientium, a multidisciplinary doctoral programme at Linköping University, Sweden. © Copyright 2019 Peter Eriksson, unless otherwise noted Peter Eriksson Cerium Oxide Nanoparticles and Gadolinium Integration; Synthesis, Characterization and Biomedical Applications ISBN: 978-91-7685-029-9 ISSN: 0345-7524 Linköping Studies in Science and Technology,
    [Show full text]
  • Thermodynamic Properties of Thorium Dioxide from 298 to 1200 Ok
    JO URNAL OF RESEARCH of the National Bureau of Standards-A. Physics and Chemistry Vol. 65, No.2, March- April 1961 Thermodynamic Properties of Thorium Dioxide From 298 to 1,200 oK Andrew C. Victor and Thomas B. Douglas (November 26, 1960) As a step in developing new standards of he.at ca l ~ac i ty applicable up to very h~gh temperatures, t he heat content (enthalpy) of thol'lum dlOxldoe, I h02 , relatn:,e to 2~3 K , was accurately measured at ten temperatures from 323 to 1,173 K . A Bunsen 1.ce ca l ol'l~neter and a drop method were used to make t he mea ~ urements on two samples of ":ldely d Iff erent bulk densities. The corresponding heat-capacity values for the hIgher denSIty sample ~re represented within t heir uncertain ty (estimated to be ± 0.3 to 0.5 %) by the followlI1g empirical equation 1 (cal mole- I deg- I at T OK) : C ~ = 17 . 057 + 1 8. 06 ( 10 -4) T - 2.5166 (1 05)/1'2 At 298 oK t his equation agrees with previously reported low-temperatu.re measurements made with an adiabatic calorimeter. Values of heat content, heat capaelty, entropy, and Gibb's free energy function are tabulated from 298.15 t o 1,200 oK. 1. Introduction measll remen ts arc soon to be extended up to ap­ proximately 1,800 OK. Current practical and theoretical developm~l!ts However, at higher temperatures aluminum oxide have increased the need for accurate heat capaCltlOs is impractical as a heat standard, for it becomes and related thermal properties at high temp ~rature s, increasingly volatile, and melts at approximately yet the values reported for the same mat~nal from 2,300 OK.
    [Show full text]
  • Extraction of Thorium Oxide from Monazite Ore
    University of Tennessee, Knoxville TRACE: Tennessee Research and Creative Exchange Supervised Undergraduate Student Research Chancellor’s Honors Program Projects and Creative Work 5-2019 Extraction of Thorium Oxide from Monazite Ore Makalee Ruch University of Tennessee, Knoxville, [email protected] Chloe Frame University of Tennessee, Knoxville Molly Landon University of Tennessee, Knoxville Ralph Laurel University of Tennessee, Knoxville Annabelle Large University of Tennessee, Knoxville Follow this and additional works at: https://trace.tennessee.edu/utk_chanhonoproj Part of the Environmental Chemistry Commons, Geological Engineering Commons, and the Other Chemical Engineering Commons Recommended Citation Ruch, Makalee; Frame, Chloe; Landon, Molly; Laurel, Ralph; and Large, Annabelle, "Extraction of Thorium Oxide from Monazite Ore" (2019). Chancellor’s Honors Program Projects. https://trace.tennessee.edu/utk_chanhonoproj/2294 This Dissertation/Thesis is brought to you for free and open access by the Supervised Undergraduate Student Research and Creative Work at TRACE: Tennessee Research and Creative Exchange. It has been accepted for inclusion in Chancellor’s Honors Program Projects by an authorized administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact [email protected]. Extraction of Thorium Oxide from Monazite Ore Dr. Robert Counce Department of Chemical and Biomolecular Engineering University of Tennessee Chloe Frame Molly Landon Annabel Large Ralph Laurel Makalee Ruch CBE 488: Honors
    [Show full text]
  • Fabrication of Thorium and Thorium Dioxide
    Natural Science, 2015, 7, 10-17 Published Online January 2015 in SciRes. http://www.scirp.org/journal/ns http://dx.doi.org/10.4236/ns.2015.71002 Fabrication of Thorium and Thorium Dioxide Balakrishna Palanki (Retired) Nuclear Fuel Complex, Hyderabad, India Email: [email protected] Received 10 November 2014; revised 9 December 2014; accepted 28 December 2014 Copyright © 2015 by author and Scientific Research Publishing Inc. This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/ Abstract Thorium based nuclear fuel is of immense interest to India by virtue of the abundance of Thorium and relative shortage of Uranium. Thorium metal tubes were being cold drawn using copper as cladding to prevent die seizure. After cold drawing, the copper was removed by dissolution in ni- tric acid. Thorium does not dissolve being passivated by nitric acid. Initially the copper cladding was carried out by inserting copper tubes inside and outside the thorium metal tube. In an inno- vative development, the mechanical cladding with copper was replaced by electroplated copper with a remarkable improvement in thorium tube acceptance rates. Oxalate derived thoria powder was found to require lower compaction pressures compared to ammonium diuranate derived urania powders to attain the same green compact density. However, the green pellets of thoria were fragile and chipped during handling. The strength improved after introducing a ball milling step before compaction and maintaining the green density above the specified value. Alternatively, binders were used later for greater handling strength. Magnesia was conventionally being used as dopant to enhance the sinterability of thoria.
    [Show full text]
  • Evaluating the Potential of Chelation Therapy to Prevent and Treat
    www.nature.com/scientificreports OPEN Evaluating the potential of chelation therapy to prevent and treat gadolinium deposition from Received: 29 December 2017 Accepted: 23 February 2018 MRI contrast agents Published: xx xx xxxx Julian A. Rees1, Gauthier J.-P. Deblonde1, Dahlia D. An 1, Camille Ansoborlo1, Stacey S. Gauny1 & Rebecca J. Abergel1,2 Several MRI contrast agent clinical formulations are now known to leave deposits of the heavy metal gadolinium in the brain, bones, and other organs of patients. This persistent biological accumulation of gadolinium has been recently recognized as a deleterious outcome in patients administered Gd- based contrast agents (GBCAs) for MRI, prompting the European Medicines Agency to recommend discontinuing the use of over half of the GBCAs currently approved for clinical applications. To address this problem, we fnd that the orally-available metal decorporation agent 3,4,3-LI(1,2- HOPO) demonstrates superior efcacy at chelating and removing Gd from the body compared to diethylenetriaminepentaacetic acid, a ligand commonly used in the United States in the GBCA Gadopentetate (Magnevist). Using the radiotracer 153Gd to obtain precise biodistribution data, the results herein, supported by speciation simulations, suggest that the prophylactic or post-hoc therapeutic use of 3,4,3-LI(1,2-HOPO) may provide a means to mitigate Gd retention in patients requiring contrast-enhanced MRI. Te use of gadolinium-based contrast agents (GBCAs) for magnetic resonance imaging (MRI) has been ubiqui- tous in radiology for nearly three decades1. Recently however, it has come to light that the suboptimal biological stability of GBCAs can lead to accumulation of Gd in patients’ bone and brain tissue, as well as to kidney damage and associated systemic conditions due to compromised renal function2–4.
    [Show full text]
  • Europium-DTPA: a Gadolinium Analogue Traceable by Fluorescence Microscopy
    1137 Dyke Award Europium-DTPA: A Gadolinium Analogue Traceable by Fluorescence Microscopy Allen D. Elster1 A lanthanide series chelate, europium(Eu)-DTPA, was synthesized to serve as a Susan C. Jackels2 histochemical analogue for the widely used MR contrast agent gadolinium(Gd)-DTPA. Nina S. Allen3 Eu and Gd, being neighboring elements on the periodic table, share many fundamental Ron C. Marrache2 properties, including ionic radius, valence, and chemical reactivity. Eu-DTPA, however, possesses one important physical property not shared by Gd-DTPA: luminescence under ultraviolet light. The feasibility of detecting Eu-DTPA in animal tissues under fluorescence microscopy was systematically evaluated and documented. Distinctive orange-red luminescence of Eu-DTPA could be observed in the kidneys, livers, dura, choroid, and pituitary glands of rats after intravascular injection. No lumi­ nescence was detected in areas of brain beyond an intact blood-brain barrier. When the brain was locally injured by an experimental laceration, however, leakage of Eu-DTPA was detected. Electron probe microanalysis confirmed the parallel presence or absence of simultaneously injected Eu-DTPA and Gd-DTPA in all tissues studied. Fluorescence microscopy with Eu-DTPA has thus been validated as a method for tracing the distri­ bution of Gd-DTPA at the microscopic level. AJNR 10:1137-1144, November/December 1989 The recent development of paramagnetic MR contrast agents such as gadolinium (Gd)-DTPA has been received by the radiologic community with justifiable enthu­ siasm. Like their iodinated counterparts in CT, MR contrast agents appear to offer increased sensitivity and specificity for detecting and characterizing a number of diseases affecting the nervous system [1-11 ].
    [Show full text]
  • Enriched Gadolinium As Burnable Absorber For
    PHYSOR 2004 – The Physics of Fuel Cycles and Advanced Nuclear Systems: Global Developments Chicago, Illinois, April 25-29, 2004, on CD-ROM, American Nuclear Society, Lagrange Park, IL. (2004) Enriched Gadolinium as Burnable Absorber for PWR Klaes-Håkan Bejmer*1 and Ola Seveborn2 1Vattenfall Bränsle AB, S-162 87 Stockholm, Sweden 2Sernanders väg 5-518, S-752 61 Uppsala, Sweden Abstract This paper is a summary of a master of thesis work in reactor physics made by Ola Seveborn. The work was done at Vattenfall Bränsle AB and Ola was guided through the work by the corresponding author of this paper. The results presented are calculations for Ringhals 3, which is a Westinhouse 3- loop PWR within the Vattenfall Group. The fuel is characterized by 17x17 assemblies of AFA type containing 3.80-3.95 w/o 235U and 8 rods containing 2 w/o Gadolinium with an enrichment of 70 w/o 157Gd. The calculations were performed with the Studsvik-Scandpower code package based on the CASMO-4 lattice code and the SIMULATE-3 nodal code. The results are compared to the corresponding calculations for fuel with 5 w/o gadolinium with natural isotopic constitution. The depletion of the cores was done separately for the reference and enriched case. The results show that the gains in average for the five cycles studied are about 70 EFPH per cycle. This is an effect of the lower gadolinium content needed. Also less parasitic absorption of enriched gadolinium in the end of the fuel life contributes to the increased cycle lengths. The abruptly increased reactivity and internal power peaking factor around 10 MWd/kgU do not affect the core design negatively.
    [Show full text]
  • Aec-Nasa Tech Brief
    March 1969 Brief 69-10079 sty C AEC-NASA TECH BRIEF YES AEC-NASA Tech Briefs describe innovations resulting from the research and development program of the U.S. AEC or from AEC-NASA interagency efforts. They are issued to encourage commercial application. Tech Briefs are published by NASA and may be purchased, at 15 cents each, from the Clearinghouse for Federal Scientific and Technical Information, Springfield, Virginia 22151. Preparation of Thorium by Magnesium—Zinc Reduction Stirring Motor Ball Valve Stuffing Box Assembly Sampling Port - Water Annulus Graphitar Bearing 1___._Hea t Shields SST Shaft Ta Thermowell Graphite Secondary Crucible Heated Ta Shaft Graphite Pouring Mold Baffled Crucible^v I SST Shell Ta Paddle THORIUM DIOXIDE REDUCTION APPARATUS A technique for the preparation of thorium metal success of the process. by magnesium—zinc reduction of thorium dioxide has The present method for commercial production of been investigated on a laboratory scale. The extent thorium metal involves metallothermic reduction of of reduction was determined as a function of time, thorium tetrafluoride with calcium in the presence of amount and composition of flux, temperature, agita- zinc chloride. However, calcium is expensive as a re- tion, particle size of the oxide, and magnesium con- ductant and the process requires a prior hydro-fluo- centration in the alloy. It was found that the use of rination step. Using magnesium—zinc alloy for the a flux of the proper composition is essential to the reduction of thorium dioxide has potential economic (continued overleaf) This document was prepared under the sponsorship of the Atomic liability resulting from the use of the information contained in this Energy Commission and/or the National Aeronautics and Space document, or warrants that the use of any information, apparatus, Administration.
    [Show full text]